Stockreport

Alnylam Pharmaceuticals (ALNY) Is Down 9.0% After Ambitious 2026 Guidance And 2030 Plan Reveal [Yahoo! Finance]

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview
PDF Morgan Healthcare Conference and issued 2026 revenue guidance, projecting combined net product revenue of US$4.90–US$5.30 billion, implying very large year-on-year growt [Read more]